HUMIRA sol inj 20 mg/0.2ml ser pré 2 x 0.2 ml

7680562210098 CH-56221 L04AB04 07.15.0.

Reimbursement limitations:

HUMIRA20mg

Le dosage de 20 mg d'HUMIRA est exclusivement réservé aux enfants et aux adolescents.

HUMIRA sol inj 20 mg/0.2ml ser pré 2 x 0.2 ml
HUMIRA sol inj 20 mg/0.2ml ser pré 2 x 0.2 ml
HUMIRA sol inj 20 mg/0.2ml ser pré 2 x 0.2 ml
1 / 3
google

Details

Product number
5622103
CPT
-
Packaging group
2
Unit
Fertigspritze(n)
Composition
Lösung: adalimumabum 20 mg, mannitolum, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml. Tela cum: alcohol isopropylicus et aqua purificata.

Articles (1)

Humira 20 mg/0.2 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/02/2025
Patient information leaflet
Français
14/02/2025
Patient information leaflet
Italien
14/02/2025
Professional SmPC
Allemand
14/02/2025
Professional SmPC
Français
14/02/2025

Detailed composition

Substance Quantity Type Category
TEL
- Substance HNIDK
SOLU
20.0 MG Substance Wirkstoff (Principe actif)
TEL
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK
SOLU
- Substance HNIDK

Reimbursement information

Public price
CHF 453.25
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/02/2019

Authorization holder

AbbVie AG

6330 Cham

Authorization information

Swissmedic authorization number
56221
Drug name
Humira, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AB04
Authorization status
Z
Dispensation category
B
First authorization
16/04/2003
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, früh diagnostizierte rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis (Morbus Bechterew), Morbus Crohn, Plaque-Psoriasis, Colitis ulcerosa, Polyartikuläre juvenile idiopathische Arthritis, Hidradenitis suppurativa, Uveitis

Packaging details

Description (FR)
HUMIRA sol inj 20 mg/0.2ml ser pré 2 x 0.2 ml
Description (DE)
HUMIRA Inj Lös 20 mg/0.2ml Fertspr 2 x 0.2 ml
Market launch
15/10/2018
Narcotic (BTM)
No

Other packaging sizes

HUMIRA sol inj 40 mg/0.4ml ser pré 0.4 ml
1 FESP
View
HUMIRA sol inj 80 mg/0.8ml ser pré 0.8 ml
1 FESP
View